Current research on CD1-restricted T cell responses, which have the potential to cause skin, respiratory, and intestinal diseases, is limited, partly due to the challenges posed by working with infectious organisms and the absence of CD1 group 1 molecules in mice [104,105]. Here, CD1B is linked to intestinal disorder.